- Home
- UBXG vs TVGN Comparison
UBXG vs TVGN Comparison
Compare UBXG & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | UBXG | TVGN |
|---|---|---|
| Founded | 2018 | 2020 |
| Country | China | United States |
| Employees | 15 | N/A |
| Industry | | Blank Checks |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.4M | 63.9M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | UBXG | TVGN |
|---|---|---|
| Price | $1.02 | $5.33 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 29.3K | ★ 34.8K |
| Earning Date | 03-23-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.03 | $0.14 |
| 52 Week High | $4.49 | $10.76 |
Technical Indicators
Market Signals| Indicator | UBXG | TVGN |
|---|---|---|
| Relative Strength Index (RSI) | 33.84 | 65.51 |
| Support Level | N/A | $0.47 |
| Resistance Level | $2.23 | $10.76 |
| Average True Range (ATR) | 0.38 | 0.51 |
| MACD | -0.07 | -0.06 |
| Stochastic Oscillator | 1.74 | 82.86 |
Price Performance
Historical ComparisonAbout UBXG U-BX Technology Ltd. Ordinary Shares
U-BX Technology Ltd focuses on providing value-added services using artificial intelligence-driven technology to businesses in the insurance industry, including insurance carriers and brokers. Its main offerings include three services/products: digital promotion services, risk assessment services, and value-added bundled benefits. The PRC operating entities help their institutional clients gain visibility on various social media platforms and generate revenue based on consumers' clicks, views, or clients' promotion time on these channels. U-BX Beijing developed a unique algorithm named the Magic Mirror. The majority of revenue comes from digital promotion services. Geographically, all of the company's revenue is derived from Mainland China.
About TVGN Tevogen Bio Holdings Inc.
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.